Agriculture biotech startup BioPrime said on Tuesday it has raised $6 million in a Series A funding round led by Edaphon and with equal participation from existing investors Omnivore and Inflexor. It is Belgium-based Edaphon's first investment in Asia.
BioPrime said in a statement it will use the investment for research in crop protection and developing bio-fungicides and bio-insecticides. The company plans to launch its range of bio-stimulants in North America, Brazil, and Southeast Asia, with trials in the United States (US) underway. BioPrime will "advance and accelerate" product development based on BioNexus, a patented technology platform that has identified more than 170 novel microbial strains from its library of 18,000.
BioPrime will move away from a one-product-fits-all approach and improve the business-to-business customer (B2B) experience by offering products customized for customer needs, it said.
Read more at Business Standard.